Share of novel drugs approved first in domestic market

Percentage of novel drugs approved in the reporting jurisdiction prior to receiving approval in other jurisdictions.

Unit Percent Industry Pharmaceuticals

Records
1
Regions
1
Period
2024
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Share of novel drugs approved first in domestic market

United States, 2024

1 observation
68% United States · 2024 · FDA · full record
Source: FDA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2024

Share of novel drugs approved first in domestic market: every record, grouped by region, newest first.
Period Value Source Type
United States 1 record
2024 68% FDA · 31 Dec 2024 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Share of novel drugs approved first in domestic market. Retrieved from https://statorigin.org/indicators/share-of-novel-drugs-approved-first-in-domestic-market